WEILIANG XU
Associate Director - Business Development PepLib
Seminars
Wednesday 30th July 2025
Peptide Radioligand Development via PepLib’s Advanced Peptide Discovery Platform
12:00 pm
• Introduction to PepLib's advanced peptide discovery platform and peptide radioligand pipelines
• Case studies on our radioligand development targeting FAP, GPC3, and DLL3
• Presentation of human IIT test results demonstrating the potency of our peptide radioligands
